Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes

OBJECTIVE: It has been postulated that prasugrel might be the preferred treatment option in diabetes mellitus (DM) patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). We aimed to compare the pharmacodynamic action of ticagrelor versus prasugrel. RESEARCH...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulos, Dimitrios, Xanthopoulou, Ioanna, Mavronasiou, Eleni, Stavrou, Katerina, Siapika, Argyro, Tsoni, Evropi, Davlouros, Periklis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714492/
https://www.ncbi.nlm.nih.gov/pubmed/23491524
http://dx.doi.org/10.2337/dc12-2510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714492/
https://www.ncbi.nlm.nih.gov/pubmed/23491524
http://dx.doi.org/10.2337/dc12-2510

Ejemplares similares